Emerging technologies, including remote tonometry and genetic risk scoring, hold promise for more efficient glaucoma care, according to a speaker at the American Glaucoma Society meeting.
“I offer remote tonometry to patients with normal-tension glaucoma and evidence of progression despite episcleral venous pressure readings in the office,” Louis R. Pasquale, MD, FARVO, of Icahn School of Medicine at Mount Sinai, told Healio.
In his presentation, he noted that “technology has allowed downsizing of tonometers,” enabling patients to perform their own diurnal curves.